PCI Brexit Communication, 3rd April 2019

On the 29th March 2019, a vote took place on the proposed first stage of the renegotiated Brexit deal by the United Kingdom (UK) Parliament. The plan was subsequently rejected and as a result, the extended deadline agreed during the EU Summit on the

PCI Brexit Communication, 15th March 2019

On 13th March, the United Kingdom (UK) Parliament voted in favour of leaving the European Union (EU) with a Brexit deal. A further vote took place on 14th March in favour of extending Article 50 (the UK/EU Withdrawal Agreement) beyond 29th March, how

PCI Brexit Communication, 17th January 2019

The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables regarding the current Brexit situation remain.

Speed, Quality & Cost – Why You Should be Conducting Your Clinical Trials in Australia – A PCI Clinical Services Webinar

Why You Should be Conducting Your Clinical Trials in Australia.

The Key Factors of Success in Clinical Packaging

Important Considerations When Initiating a Clinical Study

Brexit: Separating Fact from Fiction – A PCI Clinical Services Webinar

PCI Clinical Services and our Guests discuss Brexit and its impact on Clinical Trials in the EU and UK

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients